But the shares theselves are still so cheap that they present the best value, IMO.
You are correct, selling calls here is a fools game except if you have no desire to see whther HEAT works or not - if you simply buy CLSN now and sell the Oct $2.50s you'd make a "freaking awesome" return annualized.
I would say that in the event of an interim success (yes, still unlikely, but I peg it at about a 20-30% chance), selling calls at whatever bumped price we see would be a good strategy. In other words, if we bumped to $17, selling Jan $20s would be a good play. Or, selling DITM calls at $10, and expecting a pullback, buying them back later.
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM